Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 EX-3.1
- 4.1 EX-4.1
- 10.1 EX-10.1
- 99.1 Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Unregistered Sales of Equity Securities; Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Other Events; Financial Statements and Exhibits
XENE similar filings
- 15 May 18 Xenon Presents XEN901 Phase 1 Clinical Update and Supporting Pre-clinical Data at 14th Eilat Conference
- 8 May 18 Entry into a Material Definitive Agreement
- 8 May 18 Xenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
- 28 Mar 18 Entry into a Material Definitive Agreement
- 15 Mar 18 Other Events
- 13 Mar 18 Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical Officer
- 7 Mar 18 Xenon Pharmaceuticals Reports 2017 Financial Results and Provides Corporate Update
Filing view
External links
